LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.79 | 27.76 | 1559 | 1605 | 0.9713 | 0.9901 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.79 | 27.76 | 114 | 1605 | 0.0710 | 0.2729 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 25.79 | 27.76 | 2131 | 1605 | 1.3276 | 1.0992 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.49 | 27.76 | 1587 | 1723 | 0.9210 | 0.9726 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.49 | 27.76 | 1632 | 1723 | 0.9471 | 0.9818 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.49 | 27.76 | 135 | 1723 | 0.0783 | 0.3042 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 27.49 | 27.76 | 2276 | 1723 | 1.3208 | 1.0957 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.19 | 27.76 | 1690 | 1863 | 0.9071 | 0.9681 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.19 | 27.76 | 1734 | 1863 | 0.9307 | 0.9765 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.19 | 27.76 | 178 | 1863 | 0.0955 | 0.3583 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.19 | 27.76 | 2449 | 1863 | 1.3144 | 1.0922 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 30.90 | 27.76 | 1834 | 2032 | 0.9024 | 0.9671 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 30.90 | 27.76 | 1876 | 2032 | 0.9231 | 0.9743 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 30.90 | 27.76 | 205 | 2032 | 0.1009 | 0.3810 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 30.90 | 27.76 | 2640 | 2032 | 1.2990 | 1.0863 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 32.60 | 27.76 | 1987 | 2235 | 0.8887 | 0.9631 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 32.60 | 27.76 | 2033 | 2235 | 0.9093 | 0.9702 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 32.60 | 27.76 | 269 | 2235 | 0.1203 | 0.4315 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 32.60 | 27.76 | 2925 | 2235 | 1.3082 | 1.0867 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 34.30 | 27.76 | 2154 | 2449 | 0.8793 | 0.9606 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 34.30 | 27.76 | 2203 | 2449 | 0.8993 | 0.9674 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 34.30 | 27.76 | 315 | 2449 | 0.1286 | 0.4562 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 34.30 | 27.76 | 3141 | 2449 | 1.2822 | 1.0784 | MN20160318_Q01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.01 | 27.76 | 2373 | 2662 | 0.8911 | 0.9653 | MN20160318_Q01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 36.01 | 27.76 | 2419 | 2662 | 0.9084 | 0.9710 | MN20160318_Q01 | D09 |